Genesis Growth Tech Acquisition Corp. (GGAA) Terminates Biolog-id Deal
Genesis Growth Tech Acquisition Corp. (NASDAQ:GGAA) announced this afternoon that it has mutually terminated its deal with French medical software firm Biolog-id.
The SPAC originally signed a $312 million memorandum of understanding with the medical software company in August 2022 and intended on financing the combination with about $257.1 million from its trust but never supplemented this with a PIPE.
...READ MORE